ASO Author Reflections: Rationale to Routinely Retest ER, PR and HER-2/neu Receptor Status in Residual Disease After Neoadjvuant Chemotherapy
- Soumy Gottipati 1, Macy Goldbach 2, Julia Tchou 3
- Soumy Gottipati 1, Macy Goldbach 2, Julia Tchou 3
- 1Department of Surgery, University of California San Francisco, San Francisco, CA, USA.
- 2Division of Breast Surgery, Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
- 3Division of Breast Surgery, Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Julia.tchou@pennmedicine.upenn.edu.
- 0Department of Surgery, University of California San Francisco, San Francisco, CA, USA.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

